Skip to main content
. 2020 Apr 16;8(1):e000234. doi: 10.1136/jitc-2019-000234

Figure 4.

Figure 4

C reactive protein (CRP) inhibits function, costimulatory and checkpoint proteins on dendritic cells (DCs). Frequency of mature (A) and immature (B) DCs treated with CRP at 10 and 40 μg/mL for 48 hours expressed costimulatory markers (CD40, CD80, CD83, CD86, PD-L1, HLA-ABC, HLA-DR and beta-2 microglobulin). Representative data are from one of five patients. Error bars are +SEM for triplicate samples assessed. **P<0.05, **p<0.01, ***p<0.001 relative to cells with no treatment.